Head-to-head · Value Score
Found vs Ro
Two GLP-1 deals, scored on the same six factors. Found lands a Value Score of 78, Ro a 74. Here's who gives you the honest lower price — and where each one bites back.
Found
#62 · Grade B- · Fair Price
Est. first month
$289/mo cash month-to-month · $169/mo on a 12-month prepay
Save ~93% vs brand-nameRo
#153 · Grade C+ · Watch List
Est. first month
Not disclosed
The verdict
Found takes it on Value Score, 78 to 74 — an est. $289/mo cash month-to-month · $169/mo on a 12-month prepay first month, though we flag its pricing to watch. Ro isn't out of it: Patients who want brand-name access and insurance navigation more than a visible low price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Found | Ro |
|---|---|---|
| Value Score | 78 (B-) | 74 (C+) |
| Est. first month | $289/mo cash month-to-month · $169/mo on a 12-month prepay | Not disclosed |
| Save vs brand-name | ~93% | — |
| Semaglutide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay | Not disclosed |
| Tirzepatide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Watch | Watch |
| Coverage | All 50 states | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Found
The widest medication bench in this ranking — compounded, brand-name and oral — priced off a membership whose $99 headline only holds if you commit for months.
Why it's a deal
- Widest medication list here: compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
- Flat pricing as the dose increases — a titration does not raise the monthly cost
- Bills insurance for the clinical visits; the site says most members pay under $30 per visit
- Runs a dedicated GLP-1 microdose program for people who want a lower starting dose
The fine print
- The $99/mo is a longer-plan floor, not a month-to-month rate — Found's own FAQ says its 3, 6 and 12-month plans are what keep the monthly cost down, so paying monthly costs more
- Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
- The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
- Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
Ro
A heavyweight platform with brand-name access — but it won't show a compounded price until you're in the funnel.
Why it's a deal
- Brand-name (Wegovy/Zepbound) access and insurance support
- Oral options
- Polished, well-funded platform
The fine print
- Does not publish compounded pricing up front — no way to compare the deal
- Premium positioning
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Found is ranked on the Found alternatives ranking, and the same list for the other side is on alternatives to Ro.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.